Did Generex ever announce who the bank was setting up the
Did Generex ever announce who the bank was setting up the NGIO IPO????
Investment Banking
Capital Markets
Equity Capital Markets
ROTH’s Equity Capital Markets (“ECM”) Team is responsible for the marketing, distribution and pricing of all lead-managed and co-managed equity offerings. Our ECM Team has extensive experience in providing direction to clients on market receptivity, valuation, timing and structure of equity offerings.
Our product focus includes:
Initial Public Offerings
Follow-On Offerings
Secondary Offerings
Registered Direct Offerings
Private Placements
Block Trades
Debt Capital Markets
ROTH’s Debt Capital Markets Team provides advisory services and full-service placement capabilities to middle-market companies across a broad array of industries. We assist clients in obtaining capital that not only addresses the client’s liquidity and financing objectives, but also optimizes the client’s capital structure. This level of experience provides critical expertise in structuring, managing and executing complex and unique transactions.
Our Debt Capital Markets Team specializes in raising all types of non-equity capital for transactions from traditional refinancings, to leveraged acquisitions, recapitalizations and restructurings including the following types of capital:
Senior Debt
Senior Stretch
Junior-Secured / 2nd Lien
Mezzanine
Convertible Debt
Bridge Financings
Since 1992:
Completed more than 100 private financings
Raised more than $2 billion
For more information, please contact:
Aaron M. Gurewitz
Managing Director
Head of Equity Capital Markets
949-720-5703
agurewitz@roth.com
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...
Continue Reading
Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...
Continue Reading
Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...
Continue Reading
From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...
Continue Reading
On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...
Continue Reading
A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...
Continue Reading
Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...
Continue Reading
New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...
Continue Reading
A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...
Continue Reading
Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...
Continue Reading